Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

LETERMOVIR vs LEUPROLIDE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

LETERMOVIR vs LEUPROLIDE: Safety Overview

Metric LETERMOVIR LEUPROLIDE
Total FAERS Reports 1,416 70,893
Deaths Reported 252 11,858
Death Rate 17.8% 16.7%
Hospitalizations 398 10,499
Average Patient Age 46.6 yrs 67.5 yrs
% Female Patients 42.7% 14.1%
FDA Approval Date Aug 30, 2024 Apr 14, 2023
Manufacturer Merck Sharp & Dohme LLC TOLMAR Inc.
Route ORAL SUBCUTANEOUS
Marketing Status Prescription Discontinued